Danny Winder Archives
Oct. 5, 2017—Nashville Mayor Megan Barry will speak during a “science day,” Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR).
Oct. 27, 2016—A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.
Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.
Jul. 28, 2016—Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain.
Jun. 22, 2016—Provost and Vice Chancellor for Academic Affairs Susan R. Wente has appointed an 18-member committee of faculty and students to conduct the national search for the Barlow Family Director of the Vanderbilt Brain Institute chaired by Randolph Blake, Centennial Professor of Psychology, and Danny Winder, director for the Vanderbilt Center for Addiction Research.
Feb. 1, 2016—A study by researchers at Vanderbilt University Medical Center is offering a glimmer of hope to alcoholics who find it hard to remain sober because their abstinence is hounded by stubborn, difficult-to-treat depression.
Nov. 6, 2014—A new light-based technology is allowing scientists to peer deep into the brain and alter animal behavior with the “flip of a switch.”
Nov. 21, 2013—Danny Winder, Ph.D., professor of Molecular Physiology and Biophysics, has been appointed associate director of the Vanderbilt Medical Scientist Training Program (MSTP), which enables future leaders in academic medicine to earn both M.D. and Ph.D. degrees.
Mar. 21, 2013—Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction.